With 5.05 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.72 million shares. The 52-week range on CLOV shows that it touched its highest point at $4.87 and its lowest point at $0.97 during that stretch. It currently has a 1-year price target of $4.69. Beta for the stock currently stands at 1.92.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLOV was down-trending over the past week, with a drop of -3.57%, but this was down by -14.41% over a month. Three-month performance dropped to -17.73% while six-month performance fell -11.61%. The stock gained 170.00% in the past year, while it has lost -5.71% so far this year. A look at the trailing 12-month EPS for CLOV yields -0.05 with Next year EPS estimates of -0.02. For the next quarter, that number is -0.01. This implies an EPS growth rate of 36.85% for this year and 67.05% for next year.
Float and Shares Shorts:
At present, 388.51 million CLOV shares are outstanding with a float of 382.10 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLOV since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.11368 being high and -$0.12126 being low. For CLOV, this leads to a yearly average estimate of -$0.11849.
